Spero Therapeutics (SPRO) Financials: Revenue & Earnings

SPRO price $1.14 -0.01 -0.44%

Ticker
SPRO
Price
$1.14
Change
-0.01 -0.44%
Market cap ?
$66.10M
P/E ?
7.64
Forward P/E ?
1.51
Dividend yield ?
0.00%
Beta ?
1.50
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
62
Value
94
Quality
86
Growth
7

Stocklytics score rationale: value 94, quality 86, growth 7.

Financials

2016201720182019202020212022202320242025
335000197900039660001814700093300003070000485790001037810004797700059619000

Spero Therapeutics, Inc. is a biopharmaceutical firm in the clinical development stage, primarily focused on discovering, advancing, and commercializing innovative treatments for multi-drug resistant (MDR) bacterial infections and rare diseases within the United States. The company's pipeline includes several key therapeutic candidates: tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic…

Fair value

SPRO fair value $29.32. Price $1.14. Price is 96% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare SPRO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.14——
2026-08-12-0.16-0.17——
2026-05-13-0.13-0.18258.00K258.00K
2026-03-260.53-0.2041.30M26.00M
2025-11-13-0.13-0.253.05M12.00M
2025-08-12-0.03-0.3811.80M11.00M
2025-05-13-0.25-0.555.87M11.00M
2025-03-27-0.38-0.359.36M6.20M
2024-11-14-0.32-0.2713.47M4.13M
2024-08-05-0.33-0.356.02M4.90M
2024-05-15-0.24-0.074.20M21.53M
2024-03-130.96-0.1071.83M18.63M
2023-11-130.02-0.1525.47M26.63M
2023-08-10-0.23-0.29788.00K11.03M
2023-05-11-0.25-0.35740.00K1.00M
2023-03-300.550.0446.30M22.87M
2022-11-14-0.33-0.341.08M5.42M
2022-08-10-0.87-0.88896.00K1.43M
2022-05-16-1.01-0.87247.00K1.93M
2022-03-31-0.90-0.802.74M4.95M
2021-11-10-0.70-0.703.06M3.06M
2021-08-05-0.63-0.775.15M5.15M
2021-05-06-0.66-0.617.30M3.67M
2021-03-11-0.68-0.771.91M—
2020-11-05-0.86-0.914.00M573.59K
2020-08-06-0.85-1.171.73M2.28M
2020-05-08-1.22-1.35169.00K1.74M
2020-03-16-1.32-1.09696.00K2.97M
2019-11-04-0.95-0.80172.00K4.15M
2019-08-08-0.74-0.572.16M1.89M
2019-05-09-0.29-0.773.81M20.76M
2019-03-14-0.60-0.761.69M2.12M
2018-11-08-0.60-0.64658.00K690.90K
2018-08-09-0.69-0.88463.00K516.68K
2018-05-10-0.74-1.311.15M1.87M
2018-04-02-1.59-1.56993.00K978.96K
2017-12-14-36.02-2.43597.00K—
2017-06-30-1.39—249.00K—
2017-03-31-0.89—140.00K—
2016-12-31-1.09—335.00K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Quarterly.

Safety score 55/100 · Moderate. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividends were paid in 6 separate years. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2015-09-16$0.012015-09-182015-10-07Quarterly
2015-06-17$0.012015-06-192015-07-07Quarterly
2015-03-18$0.012015-03-202015-04-07Quarterly
2014-12-17$0.012014-12-192015-01-06Quarterly
2014-09-17$0.012014-09-192014-10-07Quarterly
2014-06-18$0.012014-06-202014-07-07Quarterly
2014-03-19$0.012014-03-212014-04-07Quarterly
2013-12-17$0.012013-12-192014-01-06Quarterly
2013-09-17$0.012013-09-192013-10-07Quarterly
2013-06-12$0.012013-06-142013-07-05Quarterly
2013-03-20$0.012013-03-222013-04-05Quarterly
2012-12-17$0.01—2013-01-07Quarterly
2012-09-17$0.01—2012-10-05Quarterly
2012-06-13$0.01—2012-07-06Quarterly
2012-03-20$0.01—2012-04-04Quarterly
2011-12-12$0.01—2012-01-05Quarterly
2011-09-14$0.01—2011-10-05Quarterly
2011-06-13$0.01—2011-07-08Quarterly
2011-03-22$0.01—2011-04-04Quarterly
2010-12-13$0.01—2010-12-31Quarterly
2010-09-29$0.01—2010-10-11Quarterly
2010-06-29$0.01—2010-07-12Quarterly
2010-03-30$0.01—2010-04-11Quarterly

Insider trades

DateInsiderActionSharesPriceValue
2026-08-03Zack DebraBuy324.68K$1.54500.00K
2026-08-03Zack DebraBuy162.31K——
2026-08-03Zack DebraOther0——
2026-06-23Deshpande MilindBuy10.00K——
2026-06-23Deshpande MilindBuy20.00K$2.1543.00K
2026-06-23Tregoning KathleenBuy10.00K——
2026-06-23Tregoning KathleenBuy20.00K$2.1543.00K
2026-06-23Smith CynthiaBuy10.00K——
2026-06-23Smith CynthiaBuy20.00K$2.1543.00K
2026-06-23VINK PATRICK V.J.J.Buy10.00K——
2026-06-23VINK PATRICK V.J.J.Buy20.00K$2.1543.00K
2026-06-23THOMAS FRANK EBuy10.00K——
2026-06-23THOMAS FRANK EBuy20.00K$2.1543.00K
2026-06-23Jackson Scott ThomasBuy10.00K——
2026-06-23Jackson Scott ThomasBuy20.00K$2.1543.00K
2026-06-23Pottage John C JrBuy10.00K——
2026-06-23Pottage John C JrBuy20.00K$2.1543.00K
2026-05-04Rajavelu EstherSell25.24K$2.5163.35K
2026-02-06Rajavelu EstherSell37.10K$2.3687.56K
2026-02-06Rajavelu EstherSell50.82K$2.36119.93K
2026-02-06Keutzer TimothySell18.65K$2.3644.02K
2026-02-04Keutzer TimothySell3.47K$2.247.78K
2026-02-03Keutzer TimothySell24.22K$2.1451.84K
2026-02-02Keutzer TimothyBuy68.00K——
2026-02-02Keutzer TimothySell18.89K$2.2041.56K
2026-02-02Keutzer TimothyBuy137.00K$2.23305.51K
2026-02-02Rajavelu EstherBuy249.00K——
2026-02-02Rajavelu EstherSell18.44K$2.2040.57K
2026-02-02Rajavelu EstherBuy498.00K$2.231.11M
2025-11-07Rajavelu EstherSell40.27K$2.3795.44K
2025-08-28Mahadevia AnkitSell6.57K$1.9712.95K
2025-08-28Keutzer TimothySell1.70K$1.973.34K
2025-06-12Mahadevia AnkitBuy20.00K——
2025-06-12Deshpande MilindBuy20.00K——
2025-06-12Jackson Scott ThomasBuy20.00K——
2025-06-12VINK PATRICK V.J.J.Buy20.00K——
2025-06-12Pottage John C JrBuy20.00K——
2025-06-12Smith CynthiaBuy20.00K——
2025-06-12THOMAS FRANK EBuy20.00K——
2025-06-12Tregoning KathleenBuy20.00K——
2025-05-02Rajavelu EstherBuy185.00K——
2025-02-05Keutzer TimothySell3.97K$0.783.10K
2025-02-05Keutzer TimothySell27.64K$0.7821.56K
2025-02-05Keutzer TimothySell24.92K$0.7819.44K
2025-02-05Rajavelu EstherSell20.69K$0.7816.14K
2025-02-05Shukla SathSell6.14K$0.784.79K
2025-02-05Shukla SathSell42.79K$0.7833.37K
2025-02-05Shukla SathSell106.41K$0.7883.00K
2025-02-05Mahadevia AnkitSell13.96K$0.7810.89K
2025-02-05Mahadevia AnkitSell55.26K$0.7843.10K
2025-02-03Keutzer TimothyBuy266.14K——
2025-02-03Rajavelu EstherBuy100.00K——
2025-02-03Rajavelu EstherBuy266.14K——
2025-02-03Shukla SathBuy751.41K——
2024-11-08Rajavelu EstherSell17.25K$1.3022.42K
2024-11-07Rajavelu EstherSell23.35K$1.3130.59K
2024-08-27Mahadevia AnkitSell5.91K$1.357.98K
2024-08-27Keutzer TimothySell2.21K$1.352.99K
2024-08-27Shukla SathSell2.76K$1.353.72K
2024-08-05Shukla SathSell17.64K$1.3123.11K
2024-08-02Shukla SathSell14.80K$1.3219.54K
2024-05-29Deshpande MilindBuy20.00K——
2024-05-29Jackson Scott ThomasBuy20.00K——
2024-05-29Mahadevia AnkitBuy20.00K——
2024-05-29VINK PATRICK V.J.J.Buy20.00K——
2024-05-29Tregoning KathleenBuy20.00K——
2024-05-29Smith CynthiaBuy20.00K——
2024-05-29THOMAS FRANK EBuy20.00K——
2024-05-29Pottage John C JrBuy20.00K——
2024-02-05Shukla SathSell45.09K$1.4565.38K
2024-02-02Keutzer TimothySell30.97K$1.3642.12K
2024-02-02Mahadevia AnkitSell63.80K$1.3787.40K
2024-02-02JOSEPH TAMARA LSell30.91K$1.3742.34K
2024-02-02HAMED KAMALSell28.07K$1.3738.46K
2024-02-02Shukla SathSell30.90K$1.3742.33K
2024-02-01Keutzer TimothyBuy239.73K——
2024-02-01JOSEPH TAMARA LBuy239.73K——
2024-02-01HAMED KAMALBuy239.73K——
2024-02-01Rajavelu EstherBuy119.87K——
2024-02-01Shukla SathBuy679.50K——
2024-01-02Tregoning KathleenBuy35.60K$1.5254.12K
2023-11-13Rajavelu EstherBuy300.00K——
2023-11-06Rajavelu EstherOther0——
2023-10-05Pottage John C JrBuy20.00K——
2023-10-05Smith CynthiaBuy20.00K——
2023-10-05THOMAS FRANK EBuy20.00K——
2023-10-05Deshpande MilindBuy20.00K——
2023-10-05Tregoning KathleenBuy20.00K——
2023-10-05VINK PATRICK V.J.J.Buy20.00K——
2023-10-05Jackson Scott ThomasBuy20.00K——
2023-10-05Mahadevia AnkitBuy20.00K——
2023-09-13HAMED KAMALSell39.50K$1.2750.16K
2023-08-29Shukla SathSell4.16K$1.305.41K
2023-08-28Keutzer TimothySell1.85K$1.262.34K
2023-08-28JOSEPH TAMARA LSell1.85K$1.262.34K
2023-08-28Mahadevia AnkitSell9.04K$1.2611.39K
2023-08-28Shukla SathSell1.85K$1.262.34K
2023-08-01Shukla SathBuy266.00K——
2023-07-15DiPalma Stephen J.Other0——
2023-06-12HAMED KAMALBuy140.00K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 66, holders +11 vs prior quarter. Ownership 37.06%.

HolderSharesChangeChange %Value
GSK PLC9.19M00.00%20.31M
PFIZER INC2.36M00.00%5.34M
VANGUARD CAPITAL MANAGEMENT LLC2.04M236.35K+13.13%4.50M
RENAISSANCE TECHNOLOGIES LLC947.90K-241.33K-20.29%2.09M
ALPHABET INC.889.98K00.00%1.97M
SUSQUEHANNA INTERNATIONAL GROUP, LLP759.29K710.79K+1465.55%1.68M
BLACKROCK, INC.594.40K161.20K+37.21%1.31M
GEODE CAPITAL MANAGEMENT, LLC566.33K46.41K+8.93%1.25M
RAYMOND JAMES FINANCIAL INC521.71K521.71KNew1.15M
TWO SIGMA INVESTMENTS, LP382.81K-502.82K-56.77%846.02K
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP332.97K332.97KNew735.86K
VANGUARD FIDUCIARY TRUST CO287.65K23.53K+8.91%635.70K
GSA CAPITAL PARTNERS LLP285.91K7.60K+2.73%632.00K
DIMENSIONAL FUND ADVISORS LP274.82K245.05K+823.21%607.62K
GOLDMAN SACHS GROUP INC256.99K256.99KNew567.94K
STATE STREET CORP214.75K00.00%474.60K
JANE STREET GROUP, LLC158.10K120.30K+318.25%349.39K
UBS GROUP AG139.68K136.67K+4542.07%308.69K
BRIDGEWAY CAPITAL MANAGEMENT, LLC114.80K00.00%253.71K
NORTHERN TRUST CORP108.27K-12.71K-10.51%239.29K
POINT72 ASSET MANAGEMENT, L.P.104.38K44.71K+74.93%230.67K
IONIC CAPITAL MANAGEMENT LLC102.70K-93.24K-47.59%226.96K
FEDERATION DES CAISSES DESJARDINS DU QUEBEC91.90K91.90KNew202.18K
SHAY CAPITAL LLC72.39K2.04K+2.90%159.98K
CITADEL ADVISORS LLC65.60K43.10K+191.56%144.98K

Earnings and financials

Spero Therapeutics, Inc. (SPRO) trades at $1.14, with a market cap of $66.10M and a trailing P/E of 7.64. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
335000197900039660001814700093300003070000485790001037810004797700059619000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Spero Therapeutics (SPRO) Financials: Revenue & Earnings

SPRO$1.14-0.01 -0.44%

$66.10M

Market Cap

7.64

P/E

1.51

Forward P/E

62

Score

Price History